IREN Limited Initial Statement of Beneficial Ownership

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Guzowski Christopher

Role Director

Type	Security	Shares	Price	Value
holding	Stock Options (Right to Buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Options (Right to Buy) — 59,576 contracts (Direct); Ordinary Shares — 11,958 shares (Direct)

Footnotes (2)

1. F1. Includes ordinary shares of IREN Limited (each, an "Ordinary Share") and outstanding restricted stock units that will vest subject to the Reporting Person's satisfaction of applicable vesting conditions.
2. F2. Represents an option to purchase Ordinary Shares (each, an "Option"). 31,205 of the Options are fully vested and exercisable and 14,188 Options will vest on July 28, 2025 and 14,183 Options will vest on July 28, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/03/2025 - 04:13 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Guzowski Christopher

(Last) (First) (Middle)

C/O IREN LIMITED

LEVEL 6, 55 MARKET STREET

(Street)

SYDNEY C3 2000

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2025

3. Issuer Name and Ticker or Trading Symbol
IREN Ltd [ IREN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	11,958(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(2)	07/28/2031	Ordinary Shares	59,576	$7.86	D

Explanation of Responses:

1. Includes ordinary shares of IREN Limited (each, an "Ordinary Share") and outstanding restricted stock units that will vest subject to the Reporting Person's satisfaction of applicable vesting conditions.

2. Represents an option to purchase Ordinary Shares (each, an "Option"). 31,205 of the Options are fully vested and exercisable and 14,188 Options will vest on July 28, 2025 and 14,183 Options will vest on July 28, 2026.

	/s/ Cesilia Kim, attorney-in-fact for Christopher Guzowski	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.